Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B C Portmann

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
The Quarterly Journal of Medicine|January 1, 1984
Hepatocellular carcinoma in the non-cirrhotic liver: a comparison with that complicating cirrhosisW M Melia, M L Wilkinson, B C Portmann, et al.
Alimentary Pharmacology & Therapeutics|April 25, 2008
Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long-term outcome and survivalT Al-Chalabi, B C Portmann, W Bernal, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1995
Ribavirin therapy for hepatitis C infection following liver transplantationE J Gane, C J Tibbs, J K Ramage, et al.
Gut|April 1, 1995
Serum intercellular adhesion molecule-1 levels in chronic hepatitis C: association with disease activity and response to interferon alphaK T Nouri-Aria, J Koskinas, C J Tibbs, et al.
Gastroenterology|June 26, 1999
p53 mutations in british patients with hepatocellular carcinoma: clustering in genetic hemochromatosisG Vautier, A B Bomford, B C Portmann, et al.
Gastroenterology|September 1, 1984
Hepatocellular carcinoma in primary biliary cirrhosis: detection by alpha-fetoprotein estimationW M Melia, P J Johnson, J Neuberger, et al.
Hepatology (Baltimore, Md.)|January 1, 1991
Dual association of HLA DR2 and DR3 with primary sclerosing cholangitisP T Donaldson, J M Farrant, M L Wilkinson, et al.
Gut|April 16, 2002
Characteristics of autoimmune hepatitis in patients who are not of European Caucasoid ethnic originT Zolfino, M A Heneghan, S Norris, et al.
Lancet (London, England)|June 15, 1985
Risk factors in development of hepatocellular carcinoma in cirrhosis: prospective study of 613 patientsS N Zaman, W M Melia, R D Johnson, et al.
Hepatology (Baltimore, Md.)|August 1, 1992
Cytomegalovirus infection persists in the liver graft in the vanishing bile duct syndromeJ C Arnold, B C Portmann, J G O'Grady, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
The Quarterly Journal of Medicine|January 1, 1984
Hepatocellular carcinoma in the non-cirrhotic liver: a comparison with that complicating cirrhosisW M Melia, M L Wilkinson, B C Portmann, et al.
Alimentary Pharmacology & Therapeutics|April 25, 2008
Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long-term outcome and survivalT Al-Chalabi, B C Portmann, W Bernal, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1995
Ribavirin therapy for hepatitis C infection following liver transplantationE J Gane, C J Tibbs, J K Ramage, et al.
Gut|April 1, 1995
Serum intercellular adhesion molecule-1 levels in chronic hepatitis C: association with disease activity and response to interferon alphaK T Nouri-Aria, J Koskinas, C J Tibbs, et al.
Gastroenterology|June 26, 1999
p53 mutations in british patients with hepatocellular carcinoma: clustering in genetic hemochromatosisG Vautier, A B Bomford, B C Portmann, et al.
Gastroenterology|September 1, 1984
Hepatocellular carcinoma in primary biliary cirrhosis: detection by alpha-fetoprotein estimationW M Melia, P J Johnson, J Neuberger, et al.
Hepatology (Baltimore, Md.)|January 1, 1991
Dual association of HLA DR2 and DR3 with primary sclerosing cholangitisP T Donaldson, J M Farrant, M L Wilkinson, et al.
Gut|April 16, 2002
Characteristics of autoimmune hepatitis in patients who are not of European Caucasoid ethnic originT Zolfino, M A Heneghan, S Norris, et al.
Lancet (London, England)|June 15, 1985
Risk factors in development of hepatocellular carcinoma in cirrhosis: prospective study of 613 patientsS N Zaman, W M Melia, R D Johnson, et al.
Hepatology (Baltimore, Md.)|August 1, 1992
Cytomegalovirus infection persists in the liver graft in the vanishing bile duct syndromeJ C Arnold, B C Portmann, J G O'Grady, et al.
Pageof 6